Atlas Trials

Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors

Clinical trial NCT05139043 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05139043
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Brain NeoplasmMetastatic Malignant Neoplasm in the BrainRecurrent Malignant Brain Neoplasm
Start date
2022-04-09
Primary completion
2025-09-03
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.